Featured in Wiley Analytical Science Magazine
- Asees Kaur
- Feb 1, 2024
- 2 min read
Updated: Jul 21
Victoria, February 2024—VoxCell BioInnovation is proud to be featured not once, but twice, in Wiley Analytical Science Magazine. The first piece, titled “Human-like cancer tissue models: Behind Canada’s first high-resolution bioprinter,” is an exclusive interview with VoxCell’s CEO, Dr. Karolina Valente, conducted by editor Róisín Murtagh. The article explores the personal story and scientific mission behind VoxCell’s formation and delves into our development of vascularized, human-relevant 3D tissue models aimed at revolutionizing cancer drug screening.
What if we could create artificial human samples for drug studies?
Dr. Karolina Valente, CEO of VoxCell BioInnovation
That question laid the foundation for our company, which focuses on engineering vascularized, human-like tissues to improve how drugs are tested significantly. We offer more predictive, ethical, and cost-effective alternatives to traditional animal and 2D in vitro testing. This feature showcases VoxCell’s role in solving one of oncology’s biggest challenges: the lack of predictive preclinical models. With drug failure rates at a high of 95%, our human-relevant 3D tissue models offer a crucial solution by identifying ineffective candidates earlier in the process. The article also examines how recent regulatory changes, such as the FDA’s endorsement of non-animal models, are generating momentum for technologies like ours.
The second feature, “Two-photon polymerization: 3D printing’s next frontier,” offers readers a deeper look into the advanced technology at the core of VoxCell’s platform. This informative article unpacks how two-photon polymerization (2PP) enables the ultra-precise 3D bioprinting required to fabricate microvascularized tissue models, a critical advancement for replicating human tissue complexity at scale. It positions 2PP as a transformative tool in bioprinting and explains how VoxCell is harnessing its potential to create perfusable, biologically relevant tissue environments.
About Wiley Analytical SCIENCE
Wiley Analytical Science is a leading online resource for scientists and researchers working across all areas of analytical chemistry. Featuring expert insights, cutting-edge research, and practical applications, the platform connects professionals with the latest innovations in techniques such as spectroscopy, chromatography, microscopy, mass spectrometry, and emerging technologies like 3D printing and microfluidics. Powered by Wiley, one of the world’s foremost publishers of scientific literature, Wiley Analytical Science delivers trusted content to support scientific advancement and cross-disciplinary collaboration.
About VoxCell BioInnovation
VoxCell BioInnovation is a leading provider of next-generation in vitro models, powered by our 3D bioprinted, vascularized tissue technology. Our ready-to-perfuse models closely replicate human biology with in vivo–like microvascular networks, enabling nutrient and oxygen delivery, systemic drug distribution, and more predictive therapeutic responses. VoxCell’s end-to-end solution offers researchers and pharmaceutical companies a scalable, ethical alternative to animal testing. Our mission is to reduce reliance on animal models, accelerate preclinical development, and advance more effective therapies for patients.
Want to learn more or collaborate?
Visit our website, connect with us on LinkedIn, or email us at hello@voxcellbio.com.
